Literature DB >> 15809215

Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's disease.

Hasmet Ayhan Hanagasi1, Dilek Ayribas, Kemal Baysal, Murat Emre.   

Abstract

A possible role of mitochondrial respiratory chain dysfunction in the pathogenesis of sporadic Parkinson's disease (PD) has been described. There are only a few reports concerning mitochondrial involvement in familial Parkinson's disease. The present study investigated mitochondrial complex I-IV activity in patients with sporadic and familial PD, compared to controls. Platelets were isolated from venous blood and platelet mitochondria were obtained through sonication and differential centrifugation. Complex I, II/III, and IV activities were measured in 17 patients with family history of Parkinson's disease (PDF), 15 patients with sporadic Parkinson disease (PDS), and 17 age-matched, healthy controls. The mitochondrial enzyme activities did not differ significantly between patient groups and controls. In addition, there was no correlation between mitochondrial complex activities and age, severity of disease, or age at onset of disease in the patient groups. In this study, the data indicate no significant differences in mitochondrial complex I-IV activities in PDF and PDS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809215     DOI: 10.1080/00207450590523017

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  17 in total

Review 1.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 2.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

3.  Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease.

Authors:  Jeff M Bronstein; Kimberly Paul; Laurice Yang; Richard H Haas; Clifford W Shults; Thuy Le; Beate Ritz
Journal:  Mov Disord       Date:  2015-03-11       Impact factor: 10.338

Review 4.  Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis.

Authors:  Jeffrey Kim; Marcel M Daadi
Journal:  Brain Res       Date:  2019-07-19       Impact factor: 3.252

Review 5.  Mitochondrial Sirtuins in Parkinson's Disease.

Authors:  Ling He; Jihong Wang; Yazhi Yang; Jian Li; Huaijun Tu
Journal:  Neurochem Res       Date:  2022-02-26       Impact factor: 3.996

6.  MtSNPscore: a combined evidence approach for assessing cumulative impact of mitochondrial variations in disease.

Authors:  Anshu Bhardwaj; Mitali Mukerji; Shipra Sharma; Jinny Paul; Chaitanya S Gokhale; Achal K Srivastava; Shrish Tiwari
Journal:  BMC Bioinformatics       Date:  2009-08-27       Impact factor: 3.169

7.  Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.

Authors:  Melinda A McFarland; Christopher E Ellis; Sanford P Markey; Robert L Nussbaum
Journal:  Mol Cell Proteomics       Date:  2008-07-09       Impact factor: 5.911

Review 8.  Mitochondrial medicine for neurodegenerative diseases.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Int J Biochem Cell Biol       Date:  2010-01-11       Impact factor: 5.085

9.  Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease.

Authors:  Pilar del Hoyo; Alberto García-Redondo; Fernando de Bustos; José Antonio Molina; Youssef Sayed; Hortensia Alonso-Navarro; Luis Caballero; Joaquín Arenas; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

10.  MitoLSDB: a comprehensive resource to study genotype to phenotype correlations in human mitochondrial DNA variations.

Authors:  Shamnamole K; Saakshi Jalali; Vinod Scaria; Anshu Bhardwaj
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.